Themis Medicare announces DCGI approval of Remifentanil Hydrochloride 1mg/2mg for injection for import and marketing
In a landmark development for Themis Medicare Ltd, the Company has received approval from Drug Controller General of India for import & marketing of Remifentanil 1 mg/2mg Powder for Concentrate for Solution for Injection.